COVID-19 patients with underlying primary mitochondrial disease and secondary m -Dys are prone to increased disease severity and CFR compared to patients with healthy mitochondrial functions 159
Water, Methylpropanediol, Glycerin, Beta-Glucan, Dimethicone, Titanium Dioxide, Niacinamide, Cyclopentasiloxane, Betaine, Polyglycerin-3, Eclipta Prostrata Leaf Extract, Laminaria Japonica Extract, 1,2-Hexanediol, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Sodium Polyacrylate, Ethylhexyl Stearate, Isohexadecane, Panthenol, Dimethiconol, Hydroxyacetophenone, Butylene Glycol, Polysorbate 80, Centella Asiatica Extract, Ficus Carica (Fig) Fruit Extract, Fragrance, Glutathione, Glycyrrhiza Glabra (Licorice) Root Extract, Lactobacillus/Rice Ferment, Sorbitan Oleate, Triethoxycaprylylsilane, Trideceth-6, Hydrogenated Lecithin, Fructooligosaccharides, Hydrogenated Polyisobutene, Squalane, Disodium Edta, Argania Spinosa Kernel Oil, Isononyl Isononanoate, Polyglyceryl-10 Stearate, Amaranthus Caudatus Seed Extract, Butyrospermum Parkii (Shea) Butter, Cetearyl Alcohol, Panax Ginseng Root Extract, Polyglyceryl-2 Dipolyhydroxystearate, Stearic Acid, Ulmus Davidiana Root Extract, Hydrolyzed Hyaluronic Acid, Inulin Lauryl Carbamate, Carbomer, Pearl Powder, Ceramide Np, Polysorbate 20, Disodium Stearoyl Glutamate, Palmitoyl Pentapeptide-4
However, if seizure onset can be determined at a later time, seizures of unknown onset can be re-categorized as either focal or generalized seizures
F.KanjS
Canonical Smad2/3 signaling is a well-established mechanism of TGF--driven extracellular-matrix (ECM) synthesis
